CIK 0000886744
- Large accelerated filer
GERON CORP
Sign in to watch- Ticker
- GERN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752287752
- Phone
- +1 650-473-7700
- Business address
- 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
- Former names
- GERON CORPORATION
- Open-market buys, last 90 days
- $50,825
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$50,825. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-06 | EASTHAM KARIN Director | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2019-06-06 | Bir Dawn Carter Director | Grant or award · Srock Option (right to buy) | +70,000 | 70,000 | ||
| 2019-04-09 | BEHRS MELISSA KELLY EVP, Chief Business Officer | Sale | −120,635 | $2.00 | $241K | 0 |
| 2019-03-29 | Spiegel Robert J. Director | Grant or award | +4,329 | 81,177 | ||
| 2019-03-29 | BRADBURY DANIEL Director | Grant or award | +9,036 | 51,323 | ||
| 2019-03-26 | O'Farrell Elizabeth G. Director | Grant or award · Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2019-03-26 | Bir Dawn Carter Director | Grant or award · Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2019-01-30 | SCARLETT JOHN A President, CEO and Chairman | Grant or award · Employee Stock Option (right to buy) | +1,050,000 | 1,050,000 | ||
| 2019-01-30 | ROSENFIELD STEPHEN EVP, Chief Legal Officer | Grant or award · Employee Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2019-01-30 | Rizo Aleksandra EVP, Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +750,000 | 750,000 | ||
| 2019-01-30 | GRETHLEIN ANDREW J EVP, Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2019-01-30 | Bloom Olivia Kyusuk EVP, Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2019-01-30 | BEHRS MELISSA KELLY EVP Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2018-12-31 | Spiegel Robert J. Director | Grant or award | +7,188 | 76,848 | ||
| 2018-12-31 | Molineaux Susan Director | Grant or award | +13,125 | 107,980 | ||
| 2018-12-31 | BRADBURY DANIEL Director | Grant or award | +15,000 | 42,287 | ||
| 2018-09-28 | Spiegel Robert J. Director | Grant or award | +4,084 | 69,660 | ||
| 2018-09-28 | Molineaux Susan Director | Grant or award | +7,457 | 94,855 | ||
| 2018-09-28 | BRADBURY DANIEL Director | Grant or award | +8,523 | 27,287 | ||
| 2018-09-13 | Spiegel Robert J. Director | Option exercise | +45,000 | $5.29 | $238K | 110,576 |
Page 12 of 15 · 290 trades